|
The ProCure Proton Therapy Center in Oklahoma City has opened its second treatment room, allowing for the expansion of the number of patients, as well as the types of tumors that the center can treat.
In achieving local control within patients with pancreatic neuroendocrine tumors, radiation therapy (RT) is a an effective treatment, according to a study published Nov. 15 in the International Journal of Radiation Oncology*Biology*Physics.
A study by researchers from the University of California, Irvine (UCI) Medical Center suggests that image-guided RapidArc radiotherapy has clinical advantages over fixed-beam approaches to stereotactic radiosurgery or stereotactic radiotherapy for treating cancer.
Post-lumpectomy radiation treatment for early-stage breast cancer can be safely reduced to four weeks by delivering a higher daily dose, according to the five-year results of a phase II study presented Wednesday at the 2009 American Society for Radiation Oncology (ASTRO) in Chicago.
Whole-brain radiation therapy and stereotactic radiosurgery, when used together in the treatment of brain tumors, present a greater risk of significant decline in learning and memory function by four months, according to a randomized trial published in the November edition of Lancet Oncology.
Simultaneous use of chemotherapy and high-dose radiotherapy has produced encouraging results in the treatment of limited-stage small-cell lung cancer, according to a phase II study presented Tuesday at the 2009 American Society for Radiation Oncology (ASTRO) meeting in Chicago.
A two-and-a-half week shorter radiation treatment for prostate cancer is as effective as a traditional seven-week treatment, according to results of a study presented Thursday at the 2009 American Society for Radiation Oncology (ASTRO) conference in Chicago.
Stereotactic radiosurgery is a treatment option for patients with early-stage, non-small cell lung cancer who are not able to undergo surgery, according to a study presented Wednesday at the American College of Chest Physicians' CHEST meeting in San Diego.
Instead of the 19 percent of proposed cuts to radiation oncology, the Centers for Medicare & Medicaid Services (CMS) has decided to implement a 5 percent reduction, phased in over a four-year period in its 2010 Medicare Physician Fee Schedule. As a result, CMS reimbursements for radiation oncology treatments will be reduced by 1 percent in 2010.
PET imaging of non-small cell lung cancer prior to receiving radiation therapy should not be the basis for determining areas that may benefit from higher doses of radiation, according to research presented today by investigators at the 51st American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.
|
The Nuclear Regulatory Commission (NRC), in a report issued last week, charged the Philadelphia Veterans Affairs (VA) Medical Center with eight violations relating to a series of bungled brachytherapy treatments for prostate cancer in which 98 men received incorrect radiation doses.
Medical isotope developer IsoRay showed a downturn in sales and profit for the Richland, Wash.-based firm's fiscal 2010 first quarter, which ended Sept. 30.
Patients who undergo lumpectomy will likely have their lumpectomy cavity decrease in volume during whole-breast irradiation, according to a study in this month's International Journal of Radiation Oncology*Biology*Physics.
Radiation therapy and chemotherapy given before prostatectomy is safe and may have the potential to reduce cancer recurrence and improve patient survival, based on study findings presented this week at the 2009 American Society of Radiology Oncology (ASTRO) conference in Chicago.
An abridged, intensified radiation course proved to be as effective as the standard five- to seven-week treatment in early-stage breast cancer patients, based on results of a study presented Wednesday at the 2009 American Society for Radiation Oncology (ASTRO) conference in Chicago.
A task force commissioned by the American Association of Physicists in Medicine (AAPM) has recommended that radiation dose delivered to the prostate and nearby organs in brachytherapy procedures should be carefully analyzed using post-implant CT or MRI and uniformly documented in each patient.
Hypofractionated radiation treatment is more effective than conventional radiation therapy for preventing cancer growth in high-risk prostate cancer patients, according to a study presented at the 2009 American Society for Radiation Oncology (ASTRO) meeting in Chicago.
Radiation therapy device developer Accuray has added the Cyberknife VSI to its family of robotic radiosurgery systems.
The use of fractionated stereotactic radiotherapy (FSR) on patients with optic nerve sheath meningiomas results in less vision loss than when patients are treated with conventional surgery, based on a study presented today at the annual meeting of the American Society for Radiation Oncology in Chicago.
Ion Beam Applications (IBA) has introduced Proteus Nano, a two-room proton therapy solution at the annual meeting of the American Society for Radiology Oncology (ASTRO) in Chicago this week.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.